| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.539 | 44.803 | 50.133 | 39.324 | 51.498 | 39.878 | 55.515 | 28.188 | 38.311 | 53.458 |
| Total Income - EUR | 48.539 | 44.804 | 50.134 | 39.464 | 51.509 | 39.879 | 55.657 | 29.578 | 59.462 | 53.458 |
| Total Expenses - EUR | 18.670 | 25.270 | 28.301 | 29.997 | 29.390 | 33.774 | 37.008 | 34.777 | 46.766 | 33.634 |
| Gross Profit/Loss - EUR | 29.869 | 19.534 | 21.833 | 9.467 | 22.120 | 6.105 | 18.650 | -5.199 | 12.696 | 19.824 |
| Net Profit/Loss - EUR | 28.412 | 19.086 | 21.332 | 9.072 | 21.605 | 5.783 | 18.093 | -5.481 | 12.204 | 19.300 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 2 |
Check the financial reports for the company - Evalmed Expert Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 180 | 178 | 335 | 329 | 154 | 151 | 148 | 18.810 | 753 | 1.307 |
| Current Assets | 33.061 | 21.588 | 26.588 | 13.869 | 23.560 | 15.259 | 21.542 | 8.186 | 12.954 | 19.344 |
| Inventories | 1.294 | 1.300 | 1.324 | 0 | 0 | 0 | 947 | 0 | 0 | 0 |
| Receivables | 10.565 | 11.358 | 14.321 | 11.281 | 18.910 | 12.694 | 10.657 | 3.843 | 3.123 | 5.756 |
| Cash | 21.202 | 8.930 | 10.942 | 2.588 | 4.650 | 2.565 | 9.937 | 4.343 | 9.831 | 13.588 |
| Shareholders Funds | 31.794 | 19.193 | 21.437 | 9.175 | 21.706 | 12.951 | 18.190 | 2.406 | 13.065 | 19.397 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 1.447 | 2.573 | 5.486 | 5.022 | 2.008 | 2.460 | 3.500 | 16.189 | 1.888 | 1.699 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.319 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6832 - 6832" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Evalmed Expert Srl